111 related articles for article (PubMed ID: 36753964)
21. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line.
Raposo LR; Silva A; Silva D; Roma-Rodrigues C; Espadinha M; Baptista PV; Santos MMM; Fernandes AR
Bioorg Med Chem; 2021 Jan; 30():115880. PubMed ID: 33348171
[TBL] [Abstract][Full Text] [Related]
22. Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.
Kurebayashi J; Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T
Cancer Sci; 2017 May; 108(5):918-930. PubMed ID: 28211214
[TBL] [Abstract][Full Text] [Related]
23. Oestrogen receptor-mediated liposomal drug delivery for treating melanoma.
Ganguly A; Rachamalla HKR; Bhattacharya D; Bhamidipati K; Pal A; Gora Ravuri H; Chakravarty S; Adhikari SS; Banerjee R
J Drug Target; 2018; 26(5-6):481-493. PubMed ID: 29376759
[TBL] [Abstract][Full Text] [Related]
24. Progesterone-Cationic Lipid Conjugate-Based Self-Aggregates for Cancer Cell-Selective Uptake through Macropinocytosis and the Antitumour Effect.
Mondal SK; Ahmed MT; Jinka S; Sarkar S; Shukla R; Banerjee R
Mol Pharm; 2023 Jun; 20(6):2822-2835. PubMed ID: 37134112
[TBL] [Abstract][Full Text] [Related]
25. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.
Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK
Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698
[TBL] [Abstract][Full Text] [Related]
26. In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG).
Xiang Q; Tang J; Luo Q; Xue J; Tao Y; Jiang H; Tian J; Fan C
Biomed Pharmacother; 2019 Mar; 111():813-820. PubMed ID: 30616080
[TBL] [Abstract][Full Text] [Related]
27. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.
Nafie MS; Arafa K; Sedky NK; Alakhdar AA; Arafa RK
Chem Biol Interact; 2020 Jun; 324():109087. PubMed ID: 32294457
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of p53-Murine Double Minute 2 (MDM2) Interactions with 3,3'-Spirocyclopentene Oxindole Derivatives.
Gicquel M; Gomez C; Garcia Alvarez MC; Pamlard O; Guérineau V; Jacquet E; Bignon J; Voituriez A; Marinetti A
J Med Chem; 2018 Oct; 61(20):9386-9392. PubMed ID: 30221935
[TBL] [Abstract][Full Text] [Related]
29. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
30. 3-Nitroacridine derivatives arrest cell cycle at G0/G1 phase and induce apoptosis in human breast cancer cells may act as DNA-target anticancer agents.
Zhou Q; You C; Zheng C; Gu Y; Gu H; Zhang R; Wu H; Sun B
Life Sci; 2018 Aug; 206():1-9. PubMed ID: 29738780
[TBL] [Abstract][Full Text] [Related]
31. Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Moriya T
Breast Cancer; 2016 May; 23(3):425-36. PubMed ID: 25552385
[TBL] [Abstract][Full Text] [Related]
32. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
33. Novel bisnaphthalimidopropyl (BNIPs) derivatives as anticancer compounds targeting DNA in human breast cancer cells.
Kopsida M; Barron GA; Bermano G; Kong Thoo Lin P; Goua M
Org Biomol Chem; 2016 Oct; 14(41):9780-9789. PubMed ID: 27722499
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel spiropyrazoline oxindoles and evaluation of cytotoxicity in cancer cell lines.
Monteiro Â; Gonçalves LM; Santos MM
Eur J Med Chem; 2014 May; 79():266-72. PubMed ID: 24747063
[TBL] [Abstract][Full Text] [Related]
35. Non-Benzoquinone Geldanamycin Analog, WK-88-1, Induces Apoptosis in Human Breast Cancer Cell Lines.
Zhao YR; Li HM; Zhu M; Li J; Ma T; Huo Q; Hong YS; Wu CZ
J Microbiol Biotechnol; 2018 Apr; 28(4):542-550. PubMed ID: 29618179
[TBL] [Abstract][Full Text] [Related]
36. Tumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancer.
Mezil L; Berruyer-Pouyet C; Cabaud O; Josselin E; Combes S; Brunel JM; Viens P; Collette Y; Birnbaum D; Lopez M
PLoS One; 2012; 7(9):e43409. PubMed ID: 23028451
[TBL] [Abstract][Full Text] [Related]
37. A Novel Naphthotriazolyl-4-oxoquinoline Derivative that Selectively Controls Breast Cancer Cells Survival Through the Induction of Apoptosis.
Branco JR; Oliveira VG; Esteves AM; Chipoline IC; Lima MFO; Boechat FCS; da Silva FC; Ferreira VF; Sola-Penna M; de Souza MCBV; Zancan P
Curr Top Med Chem; 2018; 18(17):1465-1474. PubMed ID: 30129412
[TBL] [Abstract][Full Text] [Related]
38. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
[TBL] [Abstract][Full Text] [Related]
39. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
[TBL] [Abstract][Full Text] [Related]
40. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
Liang Y; Zhou Y; Deng S; Chen T
ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]